Company / Operating Margin
Tango Therapeutics, Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-178.4%
FY2025
5-year range
-681.8% / -157.1%
FY2021-FY2025
Trend
+48.5%
vs FY2024
Sector context
#96 of 136
Health Care
What the data says
At -178.4%, Tango Therapeutics, Inc.'s operating margin ranks #96 of 136 in the Health Care sector. Operating Margin returned to growth in FY2025 after 2 years of decline, reaching -178.4%.
Based on SEC 10-K filings.
-178.4% in FY2025 with a 3-year CAGR of -21.3%.
Improved from -312.6% to -178.4% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -21.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#96 of 136 in Health CareTop 71% of 136This company -178.4% Sector average -778.9%
▼
+77.1% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 48.5% year-over-year.
- Currently 600.5pp above the Health Care sector average.
- Peak operating margin was recorded in FY2022.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -178.4% | +48.5% |
| FY2024 | -346.1% | -10.7% |
| FY2023 | -312.6% | -99.0% |
| FY2022 | -157.1% | +77.0% |
| FY2021 | -681.8% | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026